384 related articles for article (PubMed ID: 24980448)
1. Sensitivity and specificity of Dickkopf-1 protein in serum for diagnosing hepatocellular carcinoma: a meta-analysis.
Zhang J; Zhao Y; Yang Q
Int J Biol Markers; 2014 Dec; 29(4):e403-10. PubMed ID: 24980448
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of serum dickkopf-1 protein in diagnosis hepatocellular carcinoma: An updated meta-analysis.
Li Z; Mou L; Gao H; Zeng Y; Tang X; Deng X; Pu Z; Ni Y; Zhan Y
Medicine (Baltimore); 2019 Aug; 98(32):e16725. PubMed ID: 31393380
[TBL] [Abstract][Full Text] [Related]
3. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
[TBL] [Abstract][Full Text] [Related]
4. Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta-analysis.
Zhang Z; Chen P; Xie H; Cao P
Cancer Med; 2020 Feb; 9(4):1349-1364. PubMed ID: 31876977
[TBL] [Abstract][Full Text] [Related]
5. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
[TBL] [Abstract][Full Text] [Related]
6. Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis.
Yi X; Yu S; Bao Y
Clin Chim Acta; 2013 Oct; 425():212-20. PubMed ID: 23954771
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis accuracy of serum glypican-3 in patients with hepatocellular carcinoma: a systematic review with meta-analysis.
Jia X; Liu J; Gao Y; Huang Y; Du Z
Arch Med Res; 2014 Oct; 45(7):580-8. PubMed ID: 25446613
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma.
Ge T; Shen Q; Wang N; Zhang Y; Ge Z; Chu W; Lv X; Zhao F; Zhao W; Fan J; Qin W
Med Oncol; 2015 Mar; 32(3):59. PubMed ID: 25652109
[TBL] [Abstract][Full Text] [Related]
9. Comparison osteopontin vs AFP for the diagnosis of HCC: a meta-analysis.
Wan HG; Xu H; Gu YM; Wang H; Xu W; Zu MH
Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):706-14. PubMed ID: 25034355
[TBL] [Abstract][Full Text] [Related]
10. A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis.
Xu C; Yan Z; Zhou L; Wang Y
J Cancer Res Clin Oncol; 2013 Aug; 139(8):1417-24. PubMed ID: 23743582
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis.
Li JJ; Lv Y; Ji H
PeerJ; 2022; 10():e14303. PubMed ID: 36348665
[TBL] [Abstract][Full Text] [Related]
12. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
Zhang J; Chen G; Zhang P; Zhang J; Li X; Gan D; Cao X; Han M; Du H; Ye Y
PLoS One; 2020; 15(2):e0228857. PubMed ID: 32053643
[TBL] [Abstract][Full Text] [Related]
13. Do combined assays of serum AFP, AFP-L3, DCP, GP73, and DKK-1 efficiently improve the clinical values of biomarkers in decision-making for hepatocellular carcinoma? A meta-analysis.
Fang YS; Wu Q; Zhao HC; Zhou Y; Ye L; Liu SS; Li XX; Du WD
Expert Rev Gastroenterol Hepatol; 2021 Sep; 15(9):1065-1076. PubMed ID: 33691550
[No Abstract] [Full Text] [Related]
14. Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma.
Vongsuvanh R; van der Poorten D; Iseli T; Strasser SI; McCaughan GW; George J
PLoS One; 2016; 11(5):e0155800. PubMed ID: 27219517
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of decarboxylation prothrombin combined with α-fetoprotein for diagnosing primary hepatocellular carcinoma.
Fu J; Li Y; Li Z; Li N
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29717027
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance and diagnostic value of serum dickkopf-1 in patients with hepatocellular carcinoma.
Fouad YM; Mohamed HI; Kamal EM; Rasek MA
Scand J Gastroenterol; 2016 Sep; 51(9):1133-7. PubMed ID: 27161933
[TBL] [Abstract][Full Text] [Related]
17. AFP-L3 for the diagnosis of early hepatocellular carcinoma: A meta-analysis.
Zhou JM; Wang T; Zhang KH
Medicine (Baltimore); 2021 Oct; 100(43):e27673. PubMed ID: 34713864
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis.
Wang X; Zhang Y; Yang N; He H; Tao X; Kou C; Jiang J
Biomed Res Int; 2020; 2020():5087643. PubMed ID: 33015170
[TBL] [Abstract][Full Text] [Related]
19. Combination of DKK1 and AFP improves diagnostic accuracy of hepatocellular carcinoma compared with either marker alone.
Erdal H; Gül Utku Ö; Karatay E; Çelik B; Elbeg Ş; Doğan İ
Turk J Gastroenterol; 2016 Jul; 27(4):375-81. PubMed ID: 27458854
[TBL] [Abstract][Full Text] [Related]
20. Association between Ras association domain family 1A promoter methylation and hepatocellular carcinoma: a meta-analysis.
Zhao ZH; Fan YC; Yang Y; Wang K
World J Gastroenterol; 2013 Nov; 19(41):7189-96. PubMed ID: 24222965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
